Literature DB >> 7888238

Sequence analysis of the glycoprotein 120 coding region of a new HIV type 1 subtype A strain (HIV-1IbNg) from Nigeria.

T M Howard1, D O Olaylele, S Rasheed.   

Abstract

Entities:  

Keywords:  Africa; Africa South Of The Sahara; Biology; Developing Countries; Diseases; English Speaking Africa; Examinations And Diagnoses; Hiv; Hiv Infections; Immunity; Immunologic Factors; Laboratory Examinations And Diagnoses; Laboratory Procedures; Nigeria; Physiology; Research Report; Viral Diseases; Western Africa

Mesh：

Substances：

Year:  1994        PMID： 7888238     DOI： 10.1089/aid.1994.10.1755

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN： 0889-2229            Impact factor:   2.205


× No keyword cloud information.
  12 in total

1.  Genetic variability of HIV-1 protease from Nigeria and correlation with protease inhibitors drug resistance.

Authors:  A C Vicente; S M Agwale; K Otsuki; O M Njouku; D Jelpe; J A Idoko; E Caride; R M Brindeiro; A Tanuri
Journal:  Virus Genes       Date:  2001-03       Impact factor: 2.332

2.  Impact of HIV type 1 subtype on drug resistance mutations in Nigerian patients failing first-line therapy.

Authors:  B Chaplin; G Eisen; J Idoko; D Onwujekwe; E Idigbe; I Adewole; W Gashau; S Meloni; A D Sarr; J L Sankalé; E Ekong; R L Murphy; P Kanki
Journal:  AIDS Res Hum Retroviruses       Date:  2010-10-21       Impact factor: 2.205

3.  Simplified strategy for detection of recombinant human immunodeficiency virus type 1 group M isolates by gag/env heteroduplex mobility assay. Study Group on Heterogeneity of HIV Epidemics in African Cities.

Authors:  L Heyndrickx; W Janssens; L Zekeng; R Musonda; S Anagonou; G Van der Auwera; S Coppens; K Vereecken; K De Witte; R Van Rampelbergh; M Kahindo; L Morison; F E McCutchan; J K Carr; J Albert; M Essex; J Goudsmit; B Asjö; M Salminen; A Buvé; G van Der Groen
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

4.  Rev-RRE Functional Activity Differs Substantially Among Primary HIV-1 Isolates.

Authors:  Patrick E Jackson; Denis M Tebit; David Rekosh; Marie-Louise Hammarskjold
Journal:  AIDS Res Hum Retroviruses       Date:  2016-06-03       Impact factor: 2.205

5.  Development of an env gp41-based heteroduplex mobility assay for rapid human immunodeficiency virus type 1 subtyping.

Authors:  S M Agwale; K E Robbins; L Odama; A Saekhou; C Zeh; A Edubio; O M Njoku; N Sani-Gwarzo; M F Gboun; F Gao; M Reitz; D Hone; T M Folks; D Pieniazek; C Wambebe; M L Kalish
Journal:  J Clin Microbiol       Date:  2001-06       Impact factor: 5.948

6.  HIV infection awareness and willingness to participate in future HIV vaccine trials across different risk groups in Abuja, Nigeria.

Authors:  Gambo Aliyu; Mukhtar Mohammad; Ahmed Saidu; Prosanta Mondal; Man Charurat; Alash'le Abimiku; Abdulsalami Nasidi; William Blattner
Journal:  AIDS Care       Date:  2010-10

7.  Development, evaluation, and validation of an oligonucleotide probe hybridization assay to subtype human immunodeficiency virus type 1 circulating recombinant form CRF02_AG.

Authors:  Harr F Njai; Gert Van der Auwera; Chiambah A Ngong; Leo Heyndrickx; Souleymane Sawadago; Hilton Whittle; Phillipe Nyambi; Robert Colebunders; Guido van der Groen; Wouter Janssens
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

8.  The role of recombination in the emergence of a complex and dynamic HIV epidemic.

Authors:  Ming Zhang; Brian Foley; Anne-Kathrin Schultz; Jennifer P Macke; Ingo Bulla; Mario Stanke; Burkhard Morgenstern; Bette Korber; Thomas Leitner
Journal:  Retrovirology       Date:  2010-03-23       Impact factor: 4.602

9.  Recombination confounds the early evolutionary history of human immunodeficiency virus type 1: subtype G is a circulating recombinant form.

Authors:  Ana B Abecasis; Philippe Lemey; Nicole Vidal; Túlio de Oliveira; Martine Peeters; Ricardo Camacho; Beth Shapiro; Andrew Rambaut; Anne-Mieke Vandamme
Journal:  J Virol       Date:  2007-06-06       Impact factor: 5.103

10.  Genetic characterization of an isolate of HIV type 1 AG recombinant form circulating in Siberia, Russia.

Authors:  P B Baryshev; V V Bogachev; N M Gashnikova
Journal:  Arch Virol       Date:  2012-08-19       Impact factor: 2.574
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.